Emily Ichikawa, FNP-C
Family · Palo Alto
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location
Hospitals listed: Tucson Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Emily Ichikawa’s office at (888) 731-8994 to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Tucson Medical CenterTucson, AZAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of TMC Healthcare, which runs 3 hospitalsPatients rate it 2 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.3 (1.06 to 1.53), Jul 2022 – Jun 2024Worse than the national rate — Postoperative respiratory failure rate: 13.76 (9.5 to 18.03) · 1,880 cases, Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.27 (0.76 to 1.77) · 9,373 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.405, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.254, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.183, Oct 2024 – Sep 2025
See every measure and the patient survey for Tucson Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 3 better, 4 the same, 1 worse of 8 measures. Readmissions: 0 better, 8 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.3 (1.06 to 1.53) | Worse | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.76 (9.5 to 18.03) · 1,880 cases | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.27 (0.76 to 1.77) · 9,373 cases | Worse | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.405 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.254 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.183 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.28 (0.46 to 2.11) · 2,356 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.05 (102.93 to 183.16) · 136 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 108 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.6 · 217 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.1 · 322 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.3 · 566 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 18 · 692 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.9 · 586 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.5 · 8,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0.02 to 0.37) · 11,561 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.16 to 0.51) · 11,986 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.49 (0.87 to 4.11) · 3,666 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.99 (0.71 to 3.28) · 1,857 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.45 (1.24 to 3.66) · 3,477 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.63 (2.76 to 8.51) · 1,813 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.31 to 3.03) · 901 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.2 · 215 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.808 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.846 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.716 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.9 · 654 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,110 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 48.2 · 324 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 11.2 · 596 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.3 · 706 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 1,314 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.8 (3.1 to 7.7) · 57 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.6 (7.1 to 15.8) · 57 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 204 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.8 · 167 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.4 · 513 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (9.5 to 17.3) · 83 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,266 cases | No different | Jan 2024 – Dec 2024 |
What patients said (3,099 patients answered, 24% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 60% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 73% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 67% |
| Doctors "always" listened carefully | 70% |
| Doctors "always" treated them with courtesy and respect | 81% |
| Patients who gave a rating of "9" or "10" (high) | 64% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 41% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$56,318
Medicare paid this office $56,318 for 364 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 237 | $23,346 | $72 |
| Short return visit (20+ min) | 98 | $5,173 | $45 |
| Transitional care management services for problem of at least moderate complexity | 34 | $5,145 | $139 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 41 | $4,581 | $112 |
| Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | 19 | $2,656 | $140 |
See all 27 services
| Return visit (30+ min) | 237 | $23,346 | $72 |
| Short return visit (20+ min) | 98 | $5,173 | $45 |
| Transitional care management services for problem of at least moderate complexity | 34 | $5,145 | $139 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 41 | $4,581 | $112 |
| Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | 19 | $2,656 | $140 |
| Long return visit (40+ min) | 12 | $1,606 | $124 |
| Insertion of needle into vein for collection of blood sample | 110 | $1,229 | $9 |
| Blood test, thyroid stimulating hormone (tsh) | 53 | $971 | $16 |
| Blood test, comprehensive group of blood chemicals | 66 | $870 | $10 |
| Vitamin d-3 level | 27 | $841 | $29 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 83 | $738 | $8 |
| Blood test, lipids (cholesterol and triglycerides) | 43 | $617 | $13 |
| Bacterial colony count, urine | 43 | $427 | $8 |
| Thyroid hormone, t3 measurement, free | 19 | $349 | $17 |
| Ferritin (blood protein) level | 15 | $254 | $13 |
| Transferrin (iron binding protein) level | 15 | $238 | $13 |
| Manual urinalysis test with examination using microscope, automated | 60 | $230 | $3 |
| Prostate cancer screening; prostate specific antigen test (psa) | 11 | $208 | $19 |
| Thyroxine (thyroid chemical), free | 21 | $203 | $9 |
| Hemoglobin a1c level | 18 | $171 | $10 |
| Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | 17 | $170 | $8 |
| Measurement c-reactive protein for detection of infection or inflammation | 21 | $132 | $5 |
| Immunologic analysis for detection of antigen or antibody | 11 | $129 | $12 |
| Iron level | 15 | $120 | $6 |
| Bacterial urine culture | 12 | $103 | $8 |
| Red blood cell sedimentation rate, to detect inflammation, automated | 20 | $64 | $3 |
| Urinalysis, manual test | 14 | $55 | $3 |
Who their Medicare patients are
364 Original Medicare patients in 2024. Average age 76 · Under 65 4% · 85 and older 17% · Women 57% · Health risk score 1.05. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 74% · Coronary heart disease 29% · Depression 24% · Chronic kidney disease 22% · Diabetes 19% · Atrial fibrillation 18% · Cancer 14% · COPD 12% · Heart failure 11% · Dementia 9% · Stroke 8%.
The office billed $157,083, Medicare allowed $74,288 and paid $56,318; for 1,625 services of 93 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 364 | 1,625 | 76 | 1.05 | $157,083 | $56,318 |
| 2023 | 503 | 2,409 | 76 | 1.09 | $240,979 | $87,959 |
| 2022 | 318 | 1,043 | 73 | 1.10 | $131,597 | $48,000 |
| 2021 | 175 | 909 | 69 | 1.12 | $151,837 | $52,228 |
| 2020 | 135 | 260 | 68 | 1.06 | $51,388 | $13,793 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 34 services
| Return visit (30+ min) | 320 | $36,555 | $75 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 95 | $10,073 | $106 |
| Transitional care management services for problem of at least moderate complexity | 59 | $8,045 | $132 |
| Short return visit (20+ min) | 124 | $7,244 | $47 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 14 | $3,941 | $282 |
| Insertion of needle into vein for collection of blood sample | 171 | $1,764 | $8 |
| Vitamin d-3 level | 50 | $1,480 | $29 |
| Blood test, thyroid stimulating hormone (tsh) | 80 | $1,448 | $16 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 17 | $1,283 | $75 |
| Long return visit (40+ min) | 11 | $1,258 | $114 |
| New patient visit (45+ min) | 17 | $1,218 | $72 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 132 | $1,152 | $8 |
| Blood test, comprehensive group of blood chemicals | 91 | $1,091 | $10 |
| Blood test, lipids (cholesterol and triglycerides) | 75 | $998 | $13 |
| Bacterial colony count, urine | 64 | $641 | $8 |
| Thyroid hormone, t3 measurement, free | 29 | $564 | $17 |
| Administration of influenza virus vaccine | 20 | $507 | $25 |
| Cyanocobalamin (vitamin b-12) level | 30 | $473 | $15 |
| Ferritin (blood protein) level | 31 | $441 | $13 |
| Hemoglobin a1c level | 44 | $429 | $9 |
| Transferrin (iron binding protein) level | 30 | $400 | $13 |
| Manual urinalysis test with examination using microscope, automated | 96 | $384 | $3 |
| Prostate cancer screening; prostate specific antigen test (psa) | 18 | $341 | $19 |
| Administration of pneumococcal vaccine | 13 | $329 | $25 |
| Thyroxine (thyroid chemical), free | 30 | $309 | $9 |
| Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution | 28 | $280 | $8 |
| Iron level | 30 | $203 | $6 |
| Bacterial urine culture | 14 | $151 | $8 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 14 | $123 | $9 |
| Bacterial culture for aerobic isolates | 14 | $111 | $7 |
| Measurement c-reactive protein for detection of infection or inflammation | 18 | $91 | $5 |
| Urine microalbumin (protein) level | 14 | $91 | $6 |
| Creatinine level to test for kidney function or muscle injury | 14 | $81 | $5 |
| Red blood cell sedimentation rate, to detect inflammation, automated | 14 | $37 | $3 |
2022: 19 services
| Return visit (30+ min) | 144 | $14,413 | $75 |
| Long return visit (40+ min) | 47 | $8,678 | $98 |
| Short return visit (20+ min) | 96 | $6,093 | $57 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 16 | $2,482 | $38 |
| Transitional care management services for problem of at least moderate complexity | 17 | $2,332 | $137 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 18 | $1,938 | $108 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 16 | $1,124 | $70 |
| Blood test, thyroid stimulating hormone (tsh) | 30 | $530 | $17 |
| Administration of influenza virus vaccine | 20 | $486 | $24 |
| Blood test, lipids (cholesterol and triglycerides) | 29 | $394 | $13 |
| Vitamin d-3 level | 13 | $377 | $29 |
| Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 44 | $366 | $8 |
| Blood test, comprehensive group of blood chemicals | 32 | $328 | $10 |
| Insertion of needle into vein for collection of blood sample | 61 | $200 | $3 |
| Thyroid hormone, t3 measurement, free | 11 | $183 | $17 |
| Bacterial colony count, urine | 21 | $166 | $8 |
| Hemoglobin a1c level | 15 | $143 | $10 |
| Thyroxine (thyroid chemical), free | 12 | $106 | $9 |
| Manual urinalysis test with examination using microscope, automated | 27 | $87 | $3 |
2021: 7 services
| Long return visit (40+ min) | 79 | $19,592 | $107 |
| Psychotherapy, 1 hour | 21 | $10,631 | $98 |
| Return visit (30+ min) | 54 | $5,387 | $77 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 24 | $3,556 | $27 |
| New patient visit (60+ min) | 19 | $2,624 | $138 |
| New patient visit (30+ min) | 14 | $880 | $63 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 12 | $422 | $35 |
2020: 4 services
| Return visit (30+ min) | 30 | $2,888 | $63 |
| Short return visit (20+ min) | 38 | $1,995 | $41 |
| New patient visit (30+ min) | 33 | $1,661 | $50 |
| New patient visit (15+ min) | 25 | $1,020 | $41 |
Medicaid work
$69,405 in 2022
Medicaid paid $69,405 for 1,213 billed services this clinician did in 2022, up to 108 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Long return visit (40+ min) | 589 | $38,038 |
| Return visit (30+ min) | 437 | $22,746 |
| New patient visit (60+ min) | 39 | $3,820 |
| Short return visit (20+ min) | 70 | $2,752 |
| New patient visit (45+ min) | 20 | $1,307 |
| OFF/OP EST MAY X REQ PHY/QHP | 58 | $743 |
| 2022 | 1,213 | 6 | 108 | $69,405 |
| 2021 | 1,616 | 5 | 98 | $107,101 |
| 2020 | 1,458 | 8 | 102 | $60,040 |
See the largest Medicaid services in earlier years
2021
| Long return visit (40+ min) | 1,112 | $81,729 |
| Return visit (30+ min) | 400 | $23,619 |
| Short return visit (20+ min) | 31 | $1,278 |
| Handling and/or conveyance of specimen for transfer from physician office to laboratory | 57 | $276 |
| OFF/OP EST MAY X REQ PHY/QHP | 16 | $199 |
2020
| Return visit (30+ min) | 395 | $20,303 |
| Short return visit (20+ min) | 422 | $15,139 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 340 | $13,395 |
| New patient visit (30+ min) | 117 | $6,438 |
| Short return visit | 68 | $1,767 |
| New patient visit (45+ min) | 33 | $1,487 |
| New patient visit (60+ min) | 13 | $1,263 |
| Handling and/or conveyance of specimen for transfer from physician office to laboratory | 70 | $249 |
Drugs they prescribed that Part D paid
$240,161
Pharmacies billed $240,161 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (72 of 2,807) in 2024. Above the middle of the specialty; the typical nurse practitioner clinician is at 0%.
2,469 generic and fewer than 11 brand-name prescriptions · $240,161 in drug cost · 204 antibiotic prescriptions to 153 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Trelegy Ellipta | 38 | $32,459 | $854 |
| Eliquis | 35 | $28,023 | $801 |
| Jardiance | 20 | $18,644 | $932 |
| Ozempic | 17 | $17,308 | $1,018 |
| Gemtesa | 13 | $11,103 | $854 |
See all 78 drugs
| Trelegy Ellipta | 38 | $32,459 | $854 |
| Eliquis | 35 | $28,023 | $801 |
| Jardiance | 20 | $18,644 | $932 |
| Ozempic | 17 | $17,308 | $1,018 |
| Gemtesa | 13 | $11,103 | $854 |
| Xarelto | 14 | $10,390 | $742 |
| Entresto | 15 | $5,847 | $390 |
| Anoro Ellipta | 11 | $5,237 | $476 |
| Rocklatan | 12 | $4,789 | $399 |
| Gabapentin | 63 | $1,944 | $31 |
| Ipratropium | 57 | $1,378 | $24 |
| Estradiol | 23 | $1,254 | $55 |
| Synthroid | 11 | $1,183 | $108 |
| Duloxetine | 23 | $1,072 | $47 |
| Atorvastatin | 123 | $1,053 | $9 |
| Albuterol Sulfate Hfa | 47 | $1,019 | $22 |
| Omeprazole | 54 | $837 | $16 |
| Famotidine | 27 | $671 | $25 |
| Solifenacin | 20 | $667 | $33 |
| Valacyclovir | 16 | $664 | $41 |
| Desvenlafaxine Succinate Er | 11 | $638 | $58 |
| Azelastine | 16 | $609 | $38 |
| Nitrofurantoin Mono-Macro | 34 | $599 | $18 |
| Levothyroxine | 57 | $586 | $10 |
| Rosuvastatin | 36 | $571 | $16 |
| Celecoxib | 15 | $544 | $36 |
| Metoprolol | 25 | $532 | $21 |
| Mirtazapine | 23 | $531 | $23 |
| Fluoxetine | 38 | $491 | $13 |
| Tamsulosin | 44 | $452 | $10 |
| Pantoprazole | 23 | $452 | $20 |
| Ezetimibe | 25 | $435 | $17 |
| Potassium Chloride | 27 | $423 | $16 |
| Amoxicillin-Clavulanate Potass | 44 | $408 | $9 |
| Venlafaxine Hcl Er | 12 | $407 | $34 |
| Pregabalin | 20 | $402 | $20 |
| Amlodipine Besylate | 94 | $398 | $4 |
| Escitalopram | 37 | $395 | $11 |
| Olmesartan Medoxomil | 19 | $382 | $20 |
| Lisinopril | 48 | $381 | $8 |
| Metformin | 52 | $357 | $7 |
| Trazodone | 32 | $354 | $11 |
| Dorzolamide-Timolol | 12 | $335 | $28 |
| Zolpidem | 27 | $329 | $12 |
| Cyclobenzaprine | 37 | $316 | $9 |
| Vitamin D2 | 15 | $286 | $19 |
| Metformin Hcl Er | 26 | $282 | $11 |
| Montelukast | 27 | $280 | $10 |
| Brimonidine | 17 | $277 | $16 |
| Hydroxyzine | 11 | $264 | $24 |
| Tramadol | 22 | $256 | $12 |
| Azithromycin | 66 | $255 | $4 |
| Simvastatin | 26 | $247 | $10 |
| Oxycodone | 21 | $241 | $11 |
| Losartan | 43 | $241 | $6 |
| Alendronate | 45 | $233 | $5 |
| Citalopram Hbr | 29 | $223 | $8 |
| Lorazepam | 25 | $217 | $9 |
| Bupropion Xl | 11 | $189 | $17 |
| Oxycodone-Acetaminophen | 15 | $188 | $13 |
| Ondansetron | 22 | $171 | $8 |
| Acyclovir | 14 | $168 | $12 |
| Prednisone | 68 | $155 | $2 |
| Propranolol | 16 | $131 | $8 |
| Meloxicam | 24 | $127 | $5 |
| Methylprednisolone | 15 | $125 | $8 |
| Hydrochlorothiazide | 27 | $124 | $5 |
| Ibuprofen | 11 | $123 | $11 |
| Mupirocin | 12 | $114 | $10 |
| Cephalexin | 19 | $97 | $5 |
| Buspirone | 11 | $97 | $9 |
| Dicyclomine | 13 | $87 | $7 |
| Metoprolol | 13 | $85 | $7 |
| Triamcinolone Acetonide | 19 | $80 | $4 |
| Fluconazole | 11 | $77 | $7 |
| Meclizine | 12 | $59 | $5 |
| Alprazolam | 29 | $50 | $2 |
| Furosemide | 19 | $44 | $2 |
Year by year
| 2024 | 2,807 | 586 | 3% (72) | None | $240,161 |
| 2023 | 2,450 | 686 | 5% (125) | 12% | $189,110 |
| 2022 | 2,921 | 467 | 8% (235) | 10% | $199,114 |
| 2021 | 2,733 | 297 | 13% (360) | 12% | $160,471 |
| 2020 | 1,168 | 214 | 15% (171) | None | $67,561 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 70 drugs
| Jardiance | 22 | $20,899 | $950 |
| Trelegy Ellipta | 13 | $18,648 | $1,434 |
| Eliquis | 18 | $15,379 | $854 |
| Myrbetriq | 12 | $10,474 | $873 |
| Lantus Solostar | 14 | $6,197 | $443 |
| Entresto | 11 | $5,451 | $496 |
| Advair Diskus | 12 | $4,560 | $380 |
| Gabapentin | 71 | $2,173 | $31 |
| Albuterol Sulfate Hfa | 47 | $1,499 | $32 |
| Levothyroxine | 63 | $1,210 | $19 |
| Mirtazapine | 26 | $1,082 | $42 |
| Duloxetine | 15 | $950 | $63 |
| Solifenacin | 13 | $911 | $70 |
| Losartan | 54 | $863 | $16 |
| Tamsulosin | 35 | $781 | $22 |
| Atorvastatin | 66 | $774 | $12 |
| Nitrofurantoin Mono-Macro | 42 | $760 | $18 |
| Famotidine | 25 | $698 | $28 |
| Fenofibrate | 11 | $631 | $57 |
| Omeprazole | 41 | $609 | $15 |
| Amlodipine Besylate | 60 | $596 | $10 |
| Olmesartan Medoxomil | 19 | $505 | $27 |
| Metoprolol | 23 | $504 | $22 |
| Lisinopril | 59 | $491 | $8 |
| Montelukast | 34 | $473 | $14 |
| Azelastine | 15 | $469 | $31 |
| Rosuvastatin | 29 | $458 | $16 |
| Ezetimibe | 16 | $455 | $28 |
| Fluoxetine | 38 | $422 | $11 |
| Potassium Chloride | 33 | $402 | $12 |
| Alendronate | 33 | $384 | $12 |
| Oxycodone-Acetaminophen | 27 | $343 | $13 |
| Cyclobenzaprine | 32 | $322 | $10 |
| Hydrocodone-Acetaminophen | 18 | $302 | $17 |
| Propranolol | 13 | $299 | $23 |
| Oxycodone | 21 | $280 | $13 |
| Ibuprofen | 26 | $280 | $11 |
| Doxycycline Hyclate | 17 | $242 | $14 |
| Prednisone | 80 | $233 | $3 |
| Azithromycin | 69 | $219 | $3 |
| Hydroxyzine | 12 | $215 | $18 |
| Tizanidine | 16 | $199 | $12 |
| Amoxicillin-Clavulanate Potass | 28 | $195 | $7 |
| Escitalopram | 13 | $194 | $15 |
| Trazodone | 21 | $191 | $9 |
| Metformin | 20 | $190 | $9 |
| Pantoprazole | 16 | $188 | $12 |
| Clonidine | 22 | $184 | $8 |
| Nystatin | 14 | $179 | $13 |
| Lorazepam | 22 | $175 | $8 |
| Ciprofloxacin | 23 | $168 | $7 |
| Diclofenac | 11 | $166 | $15 |
| Fluconazole | 19 | $164 | $9 |
| Pravastatin | 11 | $160 | $15 |
| Ondansetron | 19 | $159 | $8 |
| Hydrochlorothiazide | 27 | $155 | $6 |
| Metformin Hcl Er | 15 | $148 | $10 |
| Meloxicam | 12 | $122 | $10 |
| Methylprednisolone | 16 | $122 | $8 |
| Cephalexin | 17 | $115 | $7 |
| Tramadol | 33 | $103 | $3 |
| Sucralfate | 13 | $87 | $7 |
| Metronidazole | 11 | $84 | $8 |
| Simvastatin | 14 | $77 | $5 |
| Sulfamethoxazole-Trimethoprim | 14 | $71 | $5 |
| Meclizine | 15 | $71 | $5 |
| Furosemide | 22 | $53 | $2 |
| Alprazolam | 20 | $36 | $2 |
| Triamcinolone Acetonide | 11 | $34 | $3 |
| Metoprolol | 11 | $27 | $2 |
2022: 80 drugs
| Januvia | 11 | $16,674 | $1,516 |
| Eliquis | 13 | $15,390 | $1,184 |
| Advair Diskus | 11 | $8,525 | $775 |
| Flovent Hfa | 11 | $5,418 | $493 |
| Symbicort | 14 | $5,107 | $365 |
| Albuterol Sulfate Hfa | 64 | $3,384 | $53 |
| Gabapentin | 77 | $3,194 | $41 |
| Oxycodone | 80 | $3,137 | $39 |
| Levothyroxine | 136 | $3,101 | $23 |
| Pregabalin | 32 | $2,146 | $67 |
| Lidocaine | 15 | $1,820 | $121 |
| Morphine Sulfate Er | 31 | $1,416 | $46 |
| Atorvastatin | 97 | $1,378 | $14 |
| Potassium Chloride | 46 | $1,361 | $30 |
| Baclofen | 53 | $1,261 | $24 |
| Tamsulosin | 49 | $1,252 | $26 |
| Omeprazole | 37 | $1,192 | $32 |
| Metoprolol | 40 | $1,128 | $28 |
| Cyclobenzaprine | 58 | $1,117 | $19 |
| Hydroxyzine | 36 | $1,114 | $31 |
| Hydrocodone-Acetaminophen | 36 | $1,113 | $31 |
| Ondansetron Odt | 42 | $974 | $23 |
| Oxycodone-Acetaminophen | 38 | $973 | $26 |
| Lisinopril | 91 | $937 | $10 |
| Fluticasone Propionate | 48 | $883 | $18 |
| Dextroamphetamine-Amphetamine | 13 | $848 | $65 |
| Montelukast | 55 | $759 | $14 |
| Amlodipine Besylate | 90 | $748 | $8 |
| Pantoprazole | 36 | $746 | $21 |
| Ibuprofen | 28 | $722 | $26 |
| Duloxetine | 26 | $619 | $24 |
| Fenofibrate | 12 | $559 | $47 |
| Celecoxib | 17 | $537 | $32 |
| Famotidine | 19 | $516 | $27 |
| Sumatriptan | 50 | $470 | $9 |
| Carvedilol | 18 | $456 | $25 |
| Trazodone | 21 | $454 | $22 |
| Pravastatin | 19 | $385 | $20 |
| Venlafaxine Hcl Er | 13 | $378 | $29 |
| Spironolactone | 14 | $370 | $26 |
| Tizanidine | 24 | $369 | $15 |
| Losartan | 41 | $360 | $9 |
| Escitalopram | 30 | $357 | $12 |
| Nitrofurantoin Mono-Macro | 20 | $344 | $17 |
| Dicyclomine | 17 | $339 | $20 |
| Morphine Sulfate | 14 | $333 | $24 |
| Clonidine | 27 | $318 | $12 |
| Metformin | 56 | $313 | $6 |
| Ondansetron | 11 | $290 | $26 |
| Glipizide Er | 24 | $279 | $12 |
| Alendronate | 14 | $273 | $19 |
| Amoxicillin-Clavulanate Potass | 25 | $265 | $11 |
| Acyclovir | 14 | $261 | $19 |
| Naproxen | 17 | $252 | $15 |
| Ropinirole | 16 | $251 | $16 |
| Triamterene-Hydrochlorothiazid | 13 | $250 | $19 |
| Azithromycin | 35 | $246 | $7 |
| Diclofenac | 14 | $246 | $18 |
| Cephalexin | 18 | $243 | $14 |
| Fluoxetine | 11 | $242 | $22 |
| Furosemide | 23 | $228 | $10 |
| Hydrochlorothiazide | 25 | $215 | $9 |
| Meclizine | 19 | $194 | $10 |
| Methylprednisolone | 23 | $180 | $8 |
| Meloxicam | 13 | $172 | $13 |
| Norethindron-Ethinyl Estradiol | 13 | $171 | $13 |
| Rosuvastatin | 15 | $138 | $9 |
| Terbinafine | 12 | $134 | $11 |
| Mupirocin | 11 | $133 | $12 |
| Losartan-Hydrochlorothiazide | 13 | $128 | $10 |
| Metoprolol | 11 | $122 | $11 |
| Prednisone | 18 | $120 | $7 |
| Glipizide | 15 | $115 | $8 |
| Lisinopril-Hydrochlorothiazide | 28 | $114 | $4 |
| Vitamin D2 | 17 | $112 | $7 |
| Rizatriptan | 15 | $111 | $7 |
| Metformin Hcl Er | 18 | $104 | $6 |
| Fluconazole | 16 | $101 | $6 |
| Ciprofloxacin | 12 | $73 | $6 |
| Triamcinolone Acetonide | 15 | $60 | $4 |
2021: 72 drugs
| Advair Diskus | 12 | $9,369 | $781 |
| Lantus | 12 | $6,657 | $555 |
| Oxycodone | 125 | $4,731 | $38 |
| Albuterol Sulfate Hfa | 71 | $4,292 | $60 |
| Levothyroxine | 99 | $2,541 | $26 |
| Gabapentin | 62 | $2,472 | $40 |
| Morphine Sulfate Er | 35 | $2,337 | $67 |
| Pregabalin | 44 | $1,990 | $45 |
| Potassium Chloride | 35 | $1,750 | $50 |
| Metoprolol | 46 | $1,586 | $34 |
| Omeprazole | 53 | $1,501 | $28 |
| Testosterone Cypionate | 16 | $1,396 | $87 |
| Trazodone | 18 | $1,377 | $76 |
| Oxycodone-Acetaminophen | 44 | $1,345 | $31 |
| Hydrocodone-Acetaminophen | 45 | $1,336 | $30 |
| Ondansetron Odt | 35 | $1,254 | $36 |
| Duloxetine | 28 | $1,231 | $44 |
| Methocarbamol | 29 | $1,076 | $37 |
| Diclofenac | 33 | $976 | $30 |
| Dextroamphetamine-Amphetamine | 15 | $907 | $60 |
| Lisinopril | 119 | $866 | $7 |
| Fluticasone Propionate | 40 | $831 | $21 |
| Rosuvastatin | 15 | $812 | $54 |
| Tizanidine | 31 | $769 | $25 |
| Atorvastatin | 72 | $733 | $10 |
| Ibuprofen | 19 | $679 | $36 |
| Hydroxyzine | 39 | $666 | $17 |
| Baclofen | 32 | $649 | $20 |
| Fenofibrate | 13 | $616 | $47 |
| Pantoprazole | 28 | $580 | $21 |
| Famotidine | 21 | $579 | $28 |
| Cyclobenzaprine | 45 | $568 | $13 |
| Dicyclomine | 19 | $549 | $29 |
| Escitalopram | 47 | $518 | $11 |
| Nitrofurantoin Mono-Macro | 24 | $451 | $19 |
| Bupropion Xl | 15 | $396 | $26 |
| Tamsulosin | 28 | $391 | $14 |
| Rizatriptan | 16 | $388 | $24 |
| Spironolactone | 14 | $387 | $28 |
| Acetaminophen-Codeine | 53 | $358 | $7 |
| Allopurinol | 13 | $350 | $27 |
| Naproxen | 19 | $348 | $18 |
| Losartan | 35 | $342 | $10 |
| Montelukast | 39 | $335 | $9 |
| Carvedilol | 13 | $255 | $20 |
| Glipizide Er | 17 | $254 | $15 |
| Meloxicam | 20 | $242 | $12 |
| Furosemide | 26 | $241 | $9 |
| Amlodipine Besylate | 54 | $229 | $4 |
| Sertraline | 16 | $221 | $14 |
| Alendronate | 15 | $215 | $14 |
| Ondansetron | 14 | $212 | $15 |
| Lisinopril-Hydrochlorothiazide | 40 | $199 | $5 |
| Sumatriptan | 22 | $177 | $8 |
| Hydrochlorothiazide | 23 | $170 | $7 |
| Clonidine | 16 | $165 | $10 |
| Hydrocortisone | 11 | $161 | $15 |
| Glipizide | 20 | $143 | $7 |
| Azithromycin | 26 | $142 | $5 |
| Losartan-Hydrochlorothiazide | 12 | $138 | $12 |
| Triamterene-Hydrochlorothiazid | 12 | $129 | $11 |
| Amoxicillin-Clavulanate Potass | 14 | $122 | $9 |
| Metformin | 26 | $113 | $4 |
| Metoprolol | 18 | $101 | $6 |
| Metformin Hcl Er | 13 | $98 | $8 |
| Prednisone | 21 | $97 | $5 |
| Methylprednisolone | 13 | $96 | $7 |
| Triamcinolone Acetonide | 14 | $87 | $6 |
| Cephalexin | 12 | $77 | $6 |
| Tramadol | 18 | $73 | $4 |
| Simvastatin | 16 | $62 | $4 |
| Alprazolam | 11 | $55 | $5 |
2020: 33 drugs
| Combivent Respimat | 13 | $5,826 | $448 |
| Oxycodone | 60 | $1,449 | $24 |
| Albuterol Sulfate Hfa | 27 | $1,103 | $41 |
| Oxycodone-Acetaminophen | 27 | $1,000 | $37 |
| Gabapentin | 27 | $930 | $34 |
| Trazodone | 27 | $851 | $32 |
| Levothyroxine | 33 | $792 | $24 |
| Proair Hfa | 11 | $789 | $72 |
| Dextroamphetamine-Amphetamine | 13 | $701 | $54 |
| Morphine Sulfate Er | 18 | $586 | $33 |
| Hydroxyzine | 25 | $584 | $23 |
| Metoprolol | 17 | $484 | $28 |
| Hydrocodone-Acetaminophen | 17 | $443 | $26 |
| Atorvastatin | 26 | $368 | $14 |
| Omeprazole | 13 | $357 | $27 |
| Lisinopril | 44 | $337 | $8 |
| Fluticasone Propionate | 17 | $318 | $19 |
| Tizanidine | 21 | $305 | $15 |
| Duloxetine | 15 | $277 | $18 |
| Amlodipine Besylate | 28 | $202 | $7 |
| Escitalopram | 13 | $189 | $15 |
| Cyclobenzaprine | 14 | $180 | $13 |
| Nitrofurantoin Mono-Macro | 11 | $169 | $15 |
| Sertraline | 11 | $164 | $15 |
| Amoxicillin-Clavulanate Potass | 19 | $159 | $8 |
| Lisinopril-Hydrochlorothiazide | 19 | $138 | $7 |
| Azithromycin | 21 | $117 | $6 |
| Acetaminophen-Codeine | 22 | $102 | $5 |
| Sumatriptan | 12 | $100 | $8 |
| Tramadol | 11 | $96 | $9 |
| Clonidine | 11 | $83 | $8 |
| Metformin | 14 | $78 | $6 |
| Prednisone | 11 | $32 | $3 |
Money from drug and device companies
$252 in 2025
| 2025 | 9 | 15 | None | $252 |
| 2024 | 23 | 109 | None | $1,895 |
| 2023 | 19 | 90 | None | $1,568 |
| 2022 | 13 | 23 | None | $593 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| GlaxoSmithKline | Trelegy Ellipta | $50 | 3 payments
|
| Pfizer | Nurtec Odt | $47 | 3 payments
|
| Astellas Pharma US | Veozah | $40 | 2 payments
|
| Phathom Pharmaceuticals | Voquezna | $29 | 2 payments
|
| Abbvie | Vraylar | $21 | 1 payment
|
| Aimmune Therapeutics | Zenpep | $19 | 1 payment
|
See all 15 published payments
| Astellas Pharma US | Meals · 2025-07-28 | Veozah | $23 |
| GlaxoSmithKline | Meals · 2025-07-07 | Trelegy Ellipta | $16 |
| Phathom Pharmaceuticals | Meals · 2025-05-28 | Voquezna | $15 |
| GlaxoSmithKline | Meals · 2025-05-09 | Trelegy Ellipta | $19 |
| GlaxoSmithKline | Meals · 2025-05-07 | Shingrix | $15 |
| Lilly USA | Meals · 2025-05-06 | Kisunla | $16 |
| Pfizer | Meals · 2025-04-30 | Nurtec Odt | $17 |
| Phathom Pharmaceuticals | Meals · 2025-04-22 | Voquezna | $14 |
| Abbvie | Meals · 2025-04-08 | Vraylar | $21 |
| Astellas Pharma US | Meals · 2025-03-31 | Veozah | $18 |
| Amgen | Meals · 2025-03-18 | Evenity | $14 |
| Novo Nordisk | Meals · 2025-03-11 | Ozempic | $16 |
| Pfizer | Meals · 2025-03-04 | Nurtec Odt | $17 |
| Pfizer | Meals · 2025-01-21 | Nurtec Odt | $14 |
| Aimmune Therapeutics | Meals · 2025-01-03 | Zenpep | $19 |
See earlier years (2024, 2023, 2022)
2024: $1,895
| Abbvie | Vraylar | $380 | 23 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $201 | 12 payments
|
| Novo Nordisk | Wegovy | $201 | 6 payments
|
| Amgen | Evenity | $166 | 9 payments
|
| AstraZeneca Pharmaceuticals LP | Airsupra | $155 | 8 payments
|
| Pfizer | Nurtec Odt | $138 | 10 payments
|
| Lilly USA | Mounjaro | $105 | 6 payments
|
| Astellas Pharma US | Veozah | $78 | 4 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $68 | 4 payments
|
| Novartis Pharmaceuticals | Leqvio | $50 | 3 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $48 | 3 payments
|
| Janssen Pharmaceuticals | Spravato | $44 | 2 payments
|
| Aimmune Therapeutics | Zenpep | $37 | 2 payments
|
| Merck Sharp & Dohme | Gardasil | $33 | 2 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $32 | 2 payments
|
| Phathom Pharmaceuticals | Voquezna | $28 | 1 payment
|
| Sumitomo Pharma America | Gemtesa | $26 | 1 payment
|
| Sanofi-Aventis U.S. | Tzield | $24 | 1 payment
|
| Exact Sciences | Cologuard Collection Kit | $20 | 1 payment
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $17 | 1 payment
|
| Amneal Pharmaceuticals | Unithroid | $16 | 1 payment
|
| Seqirus USA | Flucelvax | $14 | 1 payment
|
| Nevro | Senza | $14 | 1 payment
|
2023: $1,568
| GlaxoSmithKline | Trelegy Ellipta | $300 | 18 payments
|
| Abbvie | Vraylar | $204 | 11 payments
|
| Pfizer | Comirnaty | $166 | 11 payments
|
| Amgen | Evenity | $166 | 9 payments
|
| Novartis Pharmaceuticals | Entresto | $132 | 6 payments
|
| Lilly USA | Mounjaro | $90 | 5 payments
|
| Janssen Pharmaceuticals | Spravato | $80 | 4 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $79 | 5 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $64 | 4 payments
|
| Exact Sciences | Cologuard Collection Kit | $52 | 3 payments
|
| Abbott Laboratories | Freestyle Libre 3 | $37 | 2 payments
|
| Novo Nordisk | Wegovy | $35 | 2 payments
|
| Sanofi-Aventis U.S. | Toujeo | $33 | 2 payments
|
| Idorsia Pharmaceuticals US | Quviviq | $33 | 2 payments
|
| Nestle Healthcare Nutrition | Zenpep | $28 | 2 payments
|
| Sumitomo Pharma America | Gemtesa | $22 | 1 payment
|
| Merck Sharp & Dohme | Gardasil 9 | $19 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | None | $13 | 1 payment
|
| Astellas Pharma US | Veozah | $13 | 1 payment
|
2022: $593
| Abbott Laboratories | Freestyle Libre 2 | $142 | 2 payments
|
| Novo Nordisk | Ozempic | $125 | 1 payment
|
| GlaxoSmithKline | Trelegy Ellipta | $57 | 4 payments
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $48 | 3 payments
|
| Amgen | Evenity | $46 | 3 payments
|
| Sanofi-Aventis U.S. | Soliqua 100/33 | $35 | 2 payments
|
| Lilly USA | Jardiance | $35 | 2 payments
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $23 | 1 payment
|
| Alkermes | Aristada | $22 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $16 | 1 payment
|
| Merck Sharp & Dohme | Gardasil 9 | $15 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $15 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | None | $14 | 1 payment
|
Professional record
- NPI
- 1255988234
- Licence
- AZ 231333
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 15333 N Pima Rd Ste 312, Scottsdale, AZ, 85260
- NPI first listed
- 2019-08-23
- NPI last updated
- 2026-05-13
- NPI record certified
- 2026-05-13
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 4254 W Orchid Ln, Chandler, AZ, 85226